These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7022795)

  • 1. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive activity of procarbazine hydrochloride in canine renal allografts by donor pretreatment.
    Varkarakis MJ; Abramczyk J; Brede HD; Murphy GP
    J Surg Oncol; 1972; 4(3):235-47. PubMed ID: 4560767
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative immunosuppression with antithymocyte serum and procarbazine: effect on kidney graft survival in dogs after donor or third-party antigen administration.
    van der Linden CJ; Harder F; Buurman WA; Fabricant AS; Greep JM; Jeekel J
    Transplant Proc; 1980 Jun; 12(2):352-4. PubMed ID: 6994306
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized prospective study of cadaver donor pretreatment in renal transplantation.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):287-9. PubMed ID: 351886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 15. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
    Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
    J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific unresponsiveness to fully allogeneic kidney allografts in rats induced by procarbazine hydrochloride and antilymphocyte serum.
    Al Mahdi N; Hutchinson IV; Brent L
    Transplantation; 1983 Nov; 36(5):480-5. PubMed ID: 6356511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor pretreatment in cadaver renal transplantation.
    Zincke H; Woods JE
    Surg Gynecol Obstet; 1977 Aug; 145(2):183-8. PubMed ID: 327596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.